Why the CSL (ASX:CSL) share price is going around in circles

The CSL Limited (ASX: CSL) share price has seemingly gone nowhere since February 2020. Is it time to give the CSL share price another look?

| More on:
Woman sitting on couch holding newspaper with shocked expression on face

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price finished March down 1.5%, largely in-line with the flat ASX 200 and 0.67% fall for the S&P/ASX Health Care (INDEXASX: XHJ). 

The CSL share price has seemingly gone nowhere since its all-time record high of $332.68 back in February 2020. Despite the lacklustre share price performance, the company has continued to lift earnings. Additionally, it has played a pivotal role in the global pandemic

Classic CSL growth  

CSL delivered a strong set of results for the six months ended 31 December. Its revenue increased 16.9% to US$5,739 million. This can be broken down into a 9% increase in CSL Behring revenue and 38% jump in Seqirus revenue. The company also acknowledges that the pandemic has tempered with Behring's performance, whilst boosting the performance of Seqirus. 

Solid revenue growth was backed by higher margins. This translated to a 45% surge in net profit after tax to US$1,810 million. 

Eyes on plasma collections 

Plasma is an essential raw material for many of CSL's therapies. Plasma collection headwinds has been a key factor that has dragged the CSL share price since the start of COVID.

The company has said that its "plasma collections have been adversely affected during the pandemic". Furthermore, collection volumes in December 2020 represented~80% of December 2019 volumes. 

Macquarie Group Ltd (ASX: MQG) provided its view on the plasma collection environment on 26 March. The note highlights that foot traffic for CSL's ~100 US-based plasma collection centres had fallen in recent weeks. This was also consistent trends across key states. Current foot traffic on a 7-day rolling average basis was below levels recorded over July-December 2020. 

The note acknowledges that there is a seasonal weakness across late-February to early-March. This is associated with the timing of annual tax returns. This should be followed up with a steady improvement from mid-March to June according to 2019 data. 

Macquarie has put more emphasis on the absence of improvement in recent weeks, resulting in a neutral rating for CSL shares. 

What's next for the CSL share price? 

CSL has continued to demonstrate earnings growth despite the disruption in its supply chain. The company has forecasted FY21 net profit after tax to be in the range of approximately US$2,170 million to US$2,265 million at constant currency. This represents a 3.2% to 7.7% increase on FY20 NPAT of US$2,103 million. 

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Interest rates written on top of pictures of houses on a computer.
Share Market News

3 ASX 200 consumer discretionary stocks to benefit from a rate cut

With an RBA rate cut expected this afternoon, it could be positive news for these three stocks. 

Read more »

Miner looking at a tablet.
Opinions

3 reasons why the Fortescue share price could still be a buy

Let’s dig into why this mining giant could be a solid buy.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Tuesday

A decent session is expected for Aussie investors today.

Read more »

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough start to the week today.

Read more »

Happy man working on his laptop.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Two funeral workers with a laptop surrounded by cofins.
Broker Notes

Macquarie just forecast this ASX 300 dividend share could surge 37%. Here's why

Atop its passive income payouts, Macquarie expects this ASX dividend stock could leap 37% in a year.

Read more »

A person in a gorilla suit leaps really high holding a banana, nearly doing the splits.
Share Gainers

Up 1,238% in a year, why is this ASX gold stock surging again on Monday?

The ASX gold stock is now well into ten-bagger range and still rising fast today.

Read more »

A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
Share Gainers

Why EOS, Gorilla Gold, Lendlease, and OFX shares are charging higher today

These shares are starting the week on a positive note. But why?

Read more »